Market Overview

Opportunity Outlook for the Global Peptide Synthesis Market (2018-2023): Opportunities in Emerging Markets in the Asia Pacific Region

Share:

Dublin, July 20, 2018 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Market by Product (Reagent, Synthesizer, Chromatography), Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), End User (Pharmaceuticals & Biotechnology, CRO), and Region - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period.

Factors such as increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers are expected to drive the growth of the market. However, the lack of a unified set of regulations for therapeutic peptides is expected to restrain the growth of this market during the forecast period.

"The solid-phase synthesis segment accounted for the largest market share and is expected to grow at the highest CAGR during the forecast period"

By technology, the peptide synthesis market is segmented into solid-phase, liquid -phase, and hybrid & recombinant technology. Solid-phase synthesis is associated with a number of advantages, such as ease of operation, easy purification, short production cycles, high-level automation, and synthesis capabilities of long peptides in small quantities of amino acids. Such advantages are expected to drive the adoption of solid-phase synthesis.

"The contract development and manufacturing organizations segment is projected to grow at the highest CAGR during the forecast period"

By end user, the market is segmented into pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic and research institutes. The contract development and manufacturing organizations segment is expected to grow at the highest CAGR during the forecast period. The increasing demand for cost-effective peptide synthesis services in drug development activities and life science research is driving the growth of this segment.

"North America is projected to have the largest market share during the forecast period (2018-2023)"

North America dominated the peptide synthesis market in 2017, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the peptide synthesis market. The large share of North America in this market can be attributed to the high prevalence of chronic diseases, increasing investments in the development of structure-based drug designs, and growing research in the fields of genomics and proteomics in the region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1 - 45%, Tier 2 - 40% and Tier 3 - 15%
  • By Designation - C-level - 41%, Director Level - 30%, Others - 29%
  • By Region - North America - 32%, Europe - 27%, Asia-Pacific - 19%, Latin America - 12%, Middle East & Africa - 10%

The major players in the peptide synthesis market are GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), Merck KGAA (Germany) and New England Peptide (US).

Key Topics Covered

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Peptide Synthesis: Market Overview
4.2 Europe: Peptide Synthesis Market, By Technology & End User (2017)
4.3 Peptide Synthesis Market: Geographic Snapshot
4.4 Peptide Synthesis: Geographic Mix

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Use of Peptides in Pharmaceutical Drugs
5.2.1.2 Increase in Research Activities and Availability of Funding for R&D
5.2.1.3 Development of Advanced Peptide Synthesizers
5.2.2 Restraints
5.2.2.1 Lack of A Unified Set of Regulations for Therapeutic Peptides
5.2.3 Opportunities
5.2.3.1 Emerging Markets in the Asia Pacific Region
5.2.4 Challenge
5.2.4.1 Issues Associated With the Route of Administration of Peptide Drugs

6 Peptide Synthesis Market, By Product
6.1 Introduction
6.2 Reagents
6.3 Equipment
6.3.1 Peptide Synthesizers
6.3.2 Chromatography Equipment
6.3.3 Lyophilizers

7 Peptide Synthesis Market, By Technology
7.1 Introduction
7.2 Solid-Phase Peptide Synthesis (SPPS)
7.3 Solution-Phase Synthesis (SPS)
7.4 Hybrid and Recombinant Technology

8 Peptide Synthesis Market, By End User
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Contract Development and Manufacturing Organization/ Contract Research Organization
8.4 Academic and Research Institutes

9 Peptide Synthesis Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.6 Middle East and Africa

10 Competitive Landscape
10.1 Overview
10.2 Competitive Scenario
10.3 Growth Strategy Matrix
10.3.1 Acquisitions
10.3.2 Product Launches
10.3.3 Agreements, Partnerships, and Collaborations
10.3.4 Expansions

11 Company Profiles
11.1 Genscript Biotech
11.2 Merck KGaA
11.3 AAPPtec
11.4 Bachem Holdings
11.5 Anaspec (A Subsidiary of Kaneka Eurogentec S.A.)
11.6 Biotage
11.7 CEM Corporation
11.8 Gyros Protein Technologies
11.9 Advanced Chemtech
11.10 NEP (New England Peptide)

For more information about this report visit https://www.researchandmarkets.com/research/7r54c8/opportunity?w=12



CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Organic Chemistry

Primary Logo

View Comments and Join the Discussion!
 
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.